US 11285194
Combination immunotherapy approach for treatment of cancer
granted A61KA61K2039/572A61K31/00
Quick answer
US patent 11285194 (Combination immunotherapy approach for treatment of cancer) held by Calidi Biotherapeutics, Inc. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Calidi Biotherapeutics, Inc.
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/572, A61K31/00, A61K35/12, A61K35/28